New Delhi, Sep 8 (PTI) Biotech startup immunitoAI on Wednesday said it has raised USD 1 million (over Rs 7 crore) in a seed funding round led by early-stage venture capital fund pi Ventures.

Existing investor Entrepreneur First also participated in the funding round.

Also Read | TCL 20 R 5G With Triple Rear Cameras Launched, Check Prices & Other Details Here.

The funds will be deployed for product development and industry partnerships, immunitoAI said in a statement.

"Our vision is to make antibody therapy a norm with the help of our technology. We plan on using this seed funding to develop our AI products and validate the predictions through biological experiments," immunitoAI, CEO and Co-founder Aridni Shah said.

Also Read | Realme Pad Confirmed To Come With 7,100mAh Battery.

pi Ventures MD Roopan Aulakh said, "Our focus at pi has been to invest in startups that are revolutionising industries using disruptive technology. This thesis is well reflected in immunitoAI, our first investment from our recently launched Fund II".

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)